Literature DB >> 11473034

Characterization of preparations of GAD65, proinsulin, and the islet tyrosine phosphatase IA-2 for use in detection of autoreactive T-cells in type 1 diabetes: report of phase II of the Second International Immunology of Diabetes Society Workshop for Standardization of T-cell assays in type 1 diabetes.

M Peakman1, T I Tree, J Endl, P van Endert, M A Atkinson, B O Roep.   

Abstract

The identification, quantification, and characterization of T-cells reactive with the islet autoantigens GAD65, proinsulin (PI), and tyrosine phosphatase-like molecules IA-2 and phogrin are major research goals in type 1 diabetes. In the Immunology of Diabetes Society First Workshop on Autoreactive T-Cells, the quality of recombinant preparations of these autoantigens was identified as a significant weakness, a finding that may account for much of the inconsistency in published studies of peripheral blood T-cell reactivity to islet autoantigens. Poor antigen quality has also hampered the development of novel technologies for the detection of islet-reactive T-cells. For these reasons, in the present study, several preparations of GAD65, PI, and IA-2 were collected and evaluated for endotoxin content, ability to stimulate a panel of relevant T-cell clones, and inhibitory effects on proliferation to unrelated third-party antigens. Through this process, we have been able to identify preparations of GAD65 and IA-2, generated in insect cells using the baculovirus expression system, that stimulate relevant clones and display low inhibitory effects on third-party antigens. In addition, we characterized a PI preparation generated in bacteria as being free of effects on proliferation to third-party antigens and low in endotoxin content. These preparations are important to promote the development of robust and sensitive assays of islet-reactive T-cells in patients with type 1 diabetes or patients at high risk for developing the disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11473034     DOI: 10.2337/diabetes.50.8.1749

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  21 in total

Review 1.  Controlling the controls: GAD65 autoreactive T cells in type 1 diabetes.

Authors:  Ake Lernmark
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

Review 2.  Autoimmune diseases: are markers ready for prediction?

Authors: 
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

3.  Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health.

Authors:  Sefina Arif; Timothy I Tree; Thomas P Astill; Jennifer M Tremble; Amanda J Bishop; Colin M Dayan; Bart O Roep; Mark Peakman
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

Review 4.  Current approaches to measuring human islet-antigen specific T cell function in type 1 diabetes.

Authors:  S I Mannering; F S Wong; I Durinovic-Belló; B Brooks-Worrell; T I Tree; C M Cilio; N C Schloot; R Mallone
Journal:  Clin Exp Immunol       Date:  2010-09-15       Impact factor: 4.330

5.  Antigen presentation of detergent-free glutamate decarboxylase (GAD65) is affected by human serum albumin as carrier protein.

Authors:  Jordan Steed; Lisa K Gilliam; Robert A Harris; Ake Lernmark; Christiane S Hampe
Journal:  J Immunol Methods       Date:  2008-03-07       Impact factor: 2.303

Review 6.  Surrogate end points in the design of immunotherapy trials: emerging lessons from type 1 diabetes.

Authors:  Bart O Roep; Mark Peakman
Journal:  Nat Rev Immunol       Date:  2010-02       Impact factor: 53.106

7.  HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease.

Authors:  Stig Tollefsen; Helene Arentz-Hansen; Burkhard Fleckenstein; Oyvind Molberg; Melinda Ráki; William W Kwok; Günther Jung; Knut E A Lundin; Ludvig M Sollid
Journal:  J Clin Invest       Date:  2006-07-27       Impact factor: 14.808

8.  Detection of GAD65 autoreactive T-cells by HLA class I tetramers in type 1 diabetic patients.

Authors:  Laura Giuliani; Raffaella Mele; Monica Di Giovine; Laura Altieri; Antonino Crinò; Lucilla Ravà; Alessandra Fierabracci
Journal:  J Biomed Biotechnol       Date:  2009-12-08

Review 9.  Antigen targets of type 1 diabetes autoimmunity.

Authors:  Bart O Roep; Mark Peakman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

Review 10.  The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure.

Authors:  Bart O Roep
Journal:  Diabetologia       Date:  2003-03-22       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.